Twist x AbTherx: Lunch and Learn

From Challenging Targets to Lead Candidates: Capturing Full Human Diversity via High-Throughput B-Cell Screening

Join us for an engaging Lunch and Learn to learn more about how Twist is leveraging the Atlas Full Human Diversity Mice for antibody discovery on the Beacon single B cell screening platform.

Speakers include: • Dan Rohrer, Chief Technology Officer, AbTherx. Dan will be sharing more on "Atlas Mouse: Next-generation human transgenics for monoclonal and multi-specific antibody therapeutics"• Colby Souders, Chief Scientific Officer, Twist Bioscience. Colby will be presenting "Hard-to-Drug to High-Affinity: Accelerating Partner Success with Twist’s Single B-Cell Discovery Engine"